Michael Enxing joins PainTEQ Board of Directors

PainTEQ, a leading medical device innovator, announced the appointment of Michael Enxing, Chief Commercial Officer of Boston Scientific Corporation, Neuromodulation Division. PainTEQ is the creator of LinQ (pronounced “link”), a minimally invasive therapy for SI joint dysfunction.

With nearly three decades of executive experience, Enxing provides commercial know-how and strategic insight for medical device businesses. Most recently, he was a key executive in the acquisition (to Boston Scientific Corporation) of Vertiflex, a privately held company focused on treating patients with spinal stenosis.

“I’m glad to join PainTEQ and help develop the commercialization strategy of the LinQ System, an advancement providing positive clinical benefits for patients currently experiencing chronic pain from SI Joint dysfunction,” said Enxing. “With innovative medical technologies like LinQ, we have an unprecedented opportunity to make meaningful long-term impact while improving quality of life.”

Enxing also worked as an executive with Nevro Corp, Cardiovascular Systems Incorporated, Vertos Medical, Tecnol, Stryker, and St. Jude Medical. Enxing’s deep and proven expertise encompasses peripheral, neuro, functional neuro, spine, pain, cardiology, and image-guided surgery markets.

“Michael contributes a wealth of experience backed by a long-successful track record,” said PainTEQ CEO Sean LaNeve. “His vast business acumen provides particular value to the board in the areas of strategic planning, pre/post-FDA development, marketing management, corporate launches, M&A, IPOs, and private investment.”

Other Executives In the News

SourcePainTEQ
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy